Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA100207
Max Phase: Preclinical
Molecular Formula: C14H12BrNO4S
Molecular Weight: 370.22
Molecule Type: Small molecule
Associated Items:
ID: ALA100207
Max Phase: Preclinical
Molecular Formula: C14H12BrNO4S
Molecular Weight: 370.22
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CS(=O)(=O)c1ccc(O)c(C(=O)Nc2ccc(Br)cc2)c1
Standard InChI: InChI=1S/C14H12BrNO4S/c1-21(19,20)11-6-7-13(17)12(8-11)14(18)16-10-4-2-9(15)3-5-10/h2-8,17H,1H3,(H,16,18)
Standard InChI Key: LRSHTCZOIAVACU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 370.22 | Molecular Weight (Monoisotopic): 368.9670 | AlogP: 2.81 | #Rotatable Bonds: 3 |
Polar Surface Area: 83.47 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 6.05 | CX Basic pKa: | CX LogP: 2.37 | CX LogD: 1.09 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.87 | Np Likeness Score: -1.60 |
1. Clark MT, Coburn RA, Evans RT, Genco RJ.. (1986) 5-(Alkylsulfonyl)salicylanilides as potential dental antiplaque agents., 29 (1): [PMID:3941411] [10.1021/jm00151a004] |
Source(1):